CUBICIN Side Effects

7017673-X | Post Procedural Haemorrhage
on Sep 17, 2010 Male patient from UNITED STATES , 58 years of age, weighting 129.0 lb, was diagnosed with infection prophylaxis and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural haemorrhage. Cubicin dosage: . During the same period patient was treated with PHENYTOIN SODIUM (View Phenytoin Sodium Review and Phenytoin Sodium Label ), COREG (View Coreg Review and Coreg Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VICODIN (View Vicodin Review and Vicodin Label ), COLACE (View Colace Review and Colace Label ). Patient was hospitalized.

7017672-8 | Chills, Hyperthermia, Myalgia
Patient was taking Cubicin (View Usage). Patient had the following side effects: chills, hyperthermia, myalgia on Sep 20, 2010 from VENEZUELA Additional patient health information: Female patient , 44 years of age, was diagnosed with cellulitis (What is cellulitis?) and. Cubicin dosage: . During the same period patient was treated with LINEZOLID (View Linezolid Review and Linezolid Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ).

7011093-X | Anxiety, Disorientation, Hallucination
Adverse event was reported on Sep 10, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) . Location: GERMANY , 53 years of age, weighting 211.6 lb, After Cubicin was administered, patient had the following side effects: anxiety (What is anxiety?), disorientation, hallucination. During the same period patient was treated with ZIENAM (View Zienam Review and Zienam Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), LAXOBERAL (View Laxoberal Review and Laxoberal Label ), EFFORTIL (View Effortil Review and Effortil Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ).

7011066-7 | Hypertensive Crisis, Multi-organ Failure, Septic Shock
on Sep 15, 2010 Male patient from GERMANY , 81 years of age, weighting 132.3 lb, was diagnosed with sepsis (What is sepsis?) and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: hypertensive crisis, multi-organ failure, septic shock. Cubicin dosage: . During the same period patient was treated with AMINO ACIDS (View Amino Acids Review and Amino Acids Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), INSULIN (View Insulin Review and Insulin Label ).


7006988-7 | Erythema Multiforme
on Sep 08, 2010 Male patient from ITALY , 64 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Cubicin (View Usage). Patient had the following side effects: erythema multiforme. Cubicin dosage: . During the same period patient was treated with PIPERACILLIN W/TAZOBACTAM (View Piperacillin W/tazobactam Review and Piperacillin W/tazobactam Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ). Patient was hospitalized.

7006986-3 | Eosinophilic Pneumonia, Haemoglobin Decreased
Patient was taking Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: eosinophilic pneumonia, haemoglobin decreased on Sep 07, 2010 from BRAZIL Additional patient health information: Female patient , 77 years of age, was diagnosed with arthritis bacterial, osteomyelitis, diabetes mellitus, retinopathy and. Cubicin dosage: . During the same period patient was treated with LINEZOLID (View Linezolid Review and Linezolid Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), GLUCOCORTICOIDS (View Glucocorticoids Review and Glucocorticoids Label ), INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ). Patient was hospitalized.

7006981-4 | Urticaria
Adverse event was reported on Sep 13, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Location: TURKEY , 48 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: urticaria. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE (View Ciprofloxacin Hydrochloride Review and Ciprofloxacin Hydrochloride Label ).

6984505-5 | Dialysis
on Sep 02, 2010 Male patient from GERMANY , 76 years of age, weighting 176.4 lb, was diagnosed with soft tissue infection, skin infection and was treated with Cubicin (View Usage). Patient had the following side effects: dialysis (What is dialysis?). Cubicin dosage: . During the same period patient was treated with TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ).

6979936-3 | Diabetic Foot, Metabolic Encephalopathy, Sepsis
on Sep 03, 2010 Male patient from INDIA , 62 years of age, weighting 103.6 lb, was diagnosed with diabetic foot infection and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: diabetic foot, metabolic encephalopathy, sepsis (What is sepsis?). Cubicin dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), BROMELAINS (View Bromelains Review and Bromelains Label ), RUTOSIDE (View Rutoside Review and Rutoside Label ), TRYPSIN (View Trypsin Review and Trypsin Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMIKACIN (View Amikacin Review and Amikacin Label ). Patient was hospitalized.

6979935-1 | Autoimmune Disorder, Pulmonary Vasculitis
Patient was taking Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune disorder, pulmonary vasculitis on Sep 06, 2010 from GREECE Additional patient health information: Female patient , 80 years of age, was diagnosed with infection (What is infection?) and. Cubicin dosage: .

6979934-X | Bronchospasm
Adverse event was reported on Aug 31, 2010 by a Female patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with osteomyelitis and. Location: FRANCE , 79 years of age, weighting 154.3 lb, Patient had the following side effects: bronchospasm. During the same period patient was treated with RIFAMPIN (View Rifampin Review and Rifampin Label ).

6971933-7 | Dyspnoea
on Sep 08, 2010 Female patient from UNITED STATES , 53 years of age, weighting 167.2 lb, was diagnosed with spinal cord infection and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: dyspnoea. Cubicin dosage: 400mg Q24h Ivdrip.

6969106-7 | Blood Creatine Phosphokinase Increased, Post Procedural Infection, Renal Failure Chronic
on May 05, 2010 Male patient from GERMANY , 72 years of age, weighting 121.3 lb, was diagnosed with procedural site reaction and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, post procedural infection, renal failure chronic. Cubicin dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), IMIPENEM (View Imipenem Review and Imipenem Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6969104-3 | Organising Pneumonia
Patient was taking Cubicin (View Usage). Patient had the following side effects: organising pneumonia on Aug 31, 2010 from DENMARK Additional patient health information: Male patient , 75 years of age, was diagnosed with endocarditis enterococcal and. Cubicin dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ).

6964735-9 | Renal Failure, Renal Tubular Necrosis
Adverse event was reported on May 05, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with device related infection and. Location: SPAIN , 80 years of age, weighting 149.9 lb, After Cubicin was administered, patient had the following side effects: renal failure, renal tubular necrosis.

6964727-X | Multi-organ Failure, Septic Shock
on Aug 27, 2010 Male patient from GERMANY , 57 years of age, weighting 266.8 lb, was diagnosed with abscess (What is abscess?), cellulitis (What is cellulitis?), sepsis (What is sepsis?), staphylococcal infection (What is staphylococcal infection?) and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure, septic shock. Cubicin dosage: .

6964699-8 | Blood Culture Positive, Bronchospasm, Staphylococcus Test Positive
on May 05, 2010 Female patient from FRANCE , 79 years of age, weighting 154.3 lb, was diagnosed with osteomyelitis and was treated with Cubicin (View Usage). Patient had the following side effects: blood culture positive, bronchospasm, staphylococcus test positive. Cubicin dosage: . During the same period patient was treated with RIFAMPIN (View Rifampin Review and Rifampin Label ).

6964698-6 | Eosinophilic Pneumonia, Pneumonia Bacterial
Patient was taking Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: eosinophilic pneumonia, pneumonia bacterial on Aug 24, 2010 from BRAZIL Additional patient health information: Female patient , 67 years of age, was diagnosed with arthritis bacterial, osteomyelitis and. Cubicin dosage: .

6964694-9 | Renal Failure Acute, Septic Shock
Adverse event was reported on Aug 25, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with endocarditis (What is endocarditis?) and. Location: FRANCE , 83 years of age, weighting 218.3 lb, Patient experienced the following unwanted or unexpected effects: renal failure acute, septic shock. During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), HMG COA REDUCTASE INHIBITORS (View Hmg Coa Reductase Inhibitors Review and Hmg Coa Reductase Inhibitors Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6945552-2 | Device Related Infection
on Aug 12, 2010 Female patient from UNITED KINGDOM , 82 years of age, was diagnosed with endocarditis staphylococcal and was treated with Cubicin (View Usage). Patient had the following side effects: device related infection. Cubicin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ).

6945543-1 | Device Related Infection, Rash
on Aug 12, 2010 Male patient from UNITED KINGDOM , 67 years of age, was diagnosed with endocarditis staphylococcal and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: device related infection, rash (What is rash?). Cubicin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ).

6945528-5 | Antimicrobial Susceptibility Test Resistant, Staphylococcal Bacteraemia, Ventricular Fibrillation
Patient was taking Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: antimicrobial susceptibility test resistant, staphylococcal bacteraemia, ventricular fibrillation on Aug 20, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, was diagnosed with staphylococcal bacteraemia and. Cubicin dosage: .

6945517-0 | Deep Vein Thrombosis, Pulmonary Eosinophilia, Pulmonary Haemorrhage
Adverse event was reported on Aug 20, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with staphylococcal infection (What is staphylococcal infection?), osteomyelitis, atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 75 years of age, weighting 179.5 lb, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary eosinophilia, pulmonary haemorrhage. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), HEPARIN (Dose Unit:25000) (View Heparin Review and Heparin Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ). Patient was hospitalized.

6945501-7 | Hypersensitivity
on Aug 24, 2010 Male patient from ITALY , 45 years of age, was diagnosed with bacterial sepsis, mediastinitis, wound infection and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: hypersensitivity. Cubicin dosage: . During the same period patient was treated with CLINDAMYCIN HYDROCHLORIDE (View Clindamycin Hydrochloride Review and Clindamycin Hydrochloride Label ).

6936735-6 |
on Aug 12, 2010 Female patient from UNITED KINGDOM , 75 years of age, was diagnosed with endocarditis (What is endocarditis?), staphylococcal infection (What is staphylococcal infection?) and was treated with Cubicin (View Usage). . Cubicin dosage: . During the same period patient was treated with FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ).

6936733-2 | Endocarditis
Patient was taking Cubicin (View Usage). Patient had the following side effects: endocarditis (What is endocarditis?) on Aug 12, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 72 years of age, was diagnosed with endocarditis (What is endocarditis?), staphylococcal infection (What is staphylococcal infection?) and. Cubicin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ).

6936727-7 |
Adverse event was reported on Aug 12, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with endocarditis (What is endocarditis?), staphylococcal infection (What is staphylococcal infection?) and. Location: UNITED KINGDOM , 61 years of age, . During the same period patient was treated with FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ), LINEZOLID (View Linezolid Review and Linezolid Label ).

6936725-3 | Dementia, Pneumonia
on Aug 13, 2010 Female patient from UNITED KINGDOM , 74 years of age, was diagnosed with wound infection staphylococcal and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?), pneumonia (What is pneumonia?). Cubicin dosage: . During the same period patient was treated with CLEXANE (View Clexane Review and Clexane Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

6934482-8 | Multi-organ Failure, Septic Shock
on Aug 02, 2010 Male patient from GERMANY , 57 years of age, weighting 266.8 lb, was diagnosed with abscess (What is abscess?), cellulitis (What is cellulitis?), sepsis (What is sepsis?), staphylococcal bacteraemia and was treated with Cubicin (View Usage). Patient had the following side effects: multi-organ failure, septic shock. Cubicin dosage: . During the same period patient was treated with CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ).

6932837-9 |
Patient was taking Cubicin (View Usage). on Aug 12, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 79 years of age, was diagnosed with endocarditis (What is endocarditis?), staphylococcal infection (What is staphylococcal infection?) and. Cubicin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ).

6932834-3 | Urticaria
Adverse event was reported on Aug 09, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Location: TURKEY , 48 years of age, Patient experienced the following unwanted or unexpected effects: urticaria. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE (View Ciprofloxacin Hydrochloride Review and Ciprofloxacin Hydrochloride Label ).

6932832-X | Cardiac Disorder, White Blood Cell Count Decreased
on Aug 12, 2010 Female patient from CANADA , 53 years of age, was treated with Cubicin (View Usage). Patient had the following side effects: cardiac disorder, white blood cell count decreased. Cubicin dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), MORPHINE (View Morphine Review and Morphine Label ), NEXIUM (View Nexium Review and Nexium Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ).

6932829-X | Chills, Oxygen Saturation Decreased, Wheezing
on Aug 12, 2010 Male patient from CANADA , 58 years of age, was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: chills, oxygen saturation decreased, wheezing. Cubicin dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), COMBIVENT (View Combivent Review and Combivent Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ).

6932826-4 | Post Procedural Pneumonia
Patient was taking Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural pneumonia on Aug 09, 2010 from UNITED STATES Additional patient health information: Male patient , 77 years of age, . Cubicin dosage: .

6932822-7 | Pneumonia
Adverse event was reported on Aug 09, 2010 by a Female patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Location: UNITED STATES , 82 years of age, Patient had the following side effects: pneumonia (What is pneumonia?).

6932814-8 | Hypersensitivity, Upper Airway Obstruction
on Aug 11, 2010 Male patient from ITALY , 45 years of age, was diagnosed with bacterial sepsis, mediastinitis, wound infection and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: hypersensitivity, upper airway obstruction. Cubicin dosage: . During the same period patient was treated with CLINDAMYCIN HYDROCHLORIDE (View Clindamycin Hydrochloride Review and Clindamycin Hydrochloride Label ).

6932812-4 | Bronchopneumonia, Cardio-respiratory Arrest, Mitral Valve Incompetence, Pulmonary Hypertension
on Aug 13, 2010 Male patient from SPAIN , 81 years of age, was diagnosed with device related infection and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopneumonia, cardio-respiratory arrest, mitral valve incompetence, pulmonary hypertension (What is pulmonary hypertension?). Cubicin dosage: . Patient was hospitalized.

6922744-X | Gastrointestinal Haemorrhage, Pulmonary Haemorrhage
Patient was taking Cubicin (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, pulmonary haemorrhage on Jun 30, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 53 years of age, weighting 149.9 lb, was diagnosed with neutropenic sepsis and. Cubicin dosage: .

6920689-2 | Creatinine Renal Clearance Decreased, Neuropathy Peripheral
Adverse event was reported on Aug 02, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with device related infection and. Location: FRANCE , 59 years of age, weighting 160.9 lb, After Cubicin was administered, patient had the following side effects: creatinine renal clearance decreased, neuropathy peripheral. During the same period patient was treated with LINEZOLID (View Linezolid Review and Linezolid Label ), IMIPENEM (View Imipenem Review and Imipenem Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), DOXYCYCLINE HYCLATE (View Doxycycline Hyclate Review and Doxycycline Hyclate Label ).

6920687-9 | Cerebrovascular Disorder, Renal Failure Acute
on Aug 02, 2010 Male patient from FRANCE , 83 years of age, weighting 218.3 lb, was diagnosed with endocarditis (What is endocarditis?) and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular disorder, renal failure acute. Cubicin dosage: . During the same period patient was treated with RIFAMPIN (View Rifampin Review and Rifampin Label ).

6920686-7 | Acute Respiratory Distress Syndrome, Hepatitis, Multi-organ Disorder, Septic Shock
on Aug 04, 2010 Female patient from INDIA , 70 years of age, weighting 132.3 lb, was diagnosed with soft tissue infection, decubitus ulcer and was treated with Cubicin (View Usage). Patient had the following side effects: acute respiratory distress syndrome, hepatitis (What is hepatitis?), multi-organ disorder, septic shock. Cubicin dosage: . During the same period patient was treated with IMIPENEM (View Imipenem Review and Imipenem Label ), TAZOBACTAM (View Tazobactam Review and Tazobactam Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ).

6914787-7 | Haemothorax, Multi-organ Failure, Pyothorax, Sepsis
Patient was taking Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: haemothorax, multi-organ failure, pyothorax, sepsis (What is sepsis?) on Jul 30, 2010 from GERMANY Additional patient health information: Male patient , 69 years of age, weighting 211.6 lb, was diagnosed with endocarditis (What is endocarditis?) and. Cubicin dosage: . During the same period patient was treated with IMIPENEM (View Imipenem Review and Imipenem Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ). Patient was hospitalized.

6914784-1 | Accidental Overdose, Blood Creatine Phosphokinase Increased, Loss Of Consciousness
Adverse event was reported on Jul 28, 2010 by a Female patient taking Cubicin (View Usage) (Dosage: ) . Location: UNITED STATES , 55 years of age, Patient experienced the following unwanted or unexpected effects: accidental overdose, blood creatine phosphokinase increased, loss of consciousness. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6914777-4 | Renal Failure, Septic Shock
on Aug 03, 2010 Male patient from ITALY , 79 years of age, was treated with Cubicin (View Usage). Patient had the following side effects: renal failure, septic shock. Cubicin dosage: .

6905371-X | Diabetic Foot, Diabetic Foot Infection, Disease Progression, Multi-organ Failure
on Jul 30, 2010 Male patient from GERMANY , 79 years of age, weighting 210.1 lb, was diagnosed with diabetic foot and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: diabetic foot, diabetic foot infection, disease progression, multi-organ failure. Cubicin dosage: .

6905365-4 | Endocarditis, Multi-organ Failure
Patient was taking Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: endocarditis (What is endocarditis?), multi-organ failure on Jul 26, 2010 from COLOMBIA Additional patient health information: Female patient , 56 years of age, was diagnosed with endocarditis (What is endocarditis?) and. Cubicin dosage: . Patient was hospitalized.

6900778-9 | Haemothorax, Multi-organ Failure, Pyothorax, Sepsis
Adverse event was reported on Jul 26, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with endocarditis (What is endocarditis?) and. Location: GERMANY , 69 years of age, weighting 211.6 lb, Patient had the following side effects: haemothorax, multi-organ failure, pyothorax, sepsis (What is sepsis?). Patient was hospitalized.

6900774-1 | Pneumonia Aspiration, Septic Shock
on Jul 23, 2010 Female patient from GREECE , 53 years of age, weighting 154.3 lb, was diagnosed with bacteraemia and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: pneumonia aspiration, septic shock. Cubicin dosage: .

6900755-8 | Acute Lung Injury, Hypersensitivity
on Jul 19, 2010 Male patient from GREECE , 28 years of age, weighting 202.8 lb, was diagnosed with soft tissue infection and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: acute lung injury, hypersensitivity. Cubicin dosage: . During the same period patient was treated with TAZOCIN (View Tazocin Review and Tazocin Label ), COLISTIN (View Colistin Review and Colistin Label ). Patient was hospitalized.

6883941-5 | Dementia, Pneumonia
Patient was taking Cubicin (View Usage). Patient had the following side effects: dementia (What is dementia?), pneumonia (What is pneumonia?) on Jul 22, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 74 years of age, was diagnosed with wound infection staphylococcal and. Cubicin dosage: . Patient was hospitalized.